Kyu Hee Hong

Kyu Hee Hong has worked in the bioanalytical field for over 20 years. In 1998, they began their career at Genentech, Inc. as a Research Associate. In 2003, they moved to the Schering-Plough Research Institute as a Scientist II, where they developed and qualified target proteins in various matrices. In 2009, they returned to Genentech, Inc. as a Principal Scientific Researcher in the Assay Development & Technology group. In 2018, they became the Director of Bioanalysis at Immune-Onc Therapeutics, where they are accountable for designing bioanalytical strategy, method development, evaluation, qualification, and outsourcing method validation and patient sample testing for monoclonal antibodies and other bio-therapeutics in the pipeline. In 2019, they were promoted to Associate Director of Bioanalysis.

Kyu Hee Hong obtained a Bachelor's Degree in Biochemistry from the University of California, Davis in 1994. Subsequently, they obtained a Master's Degree in Nutrition from the same university in 1998.